Galderma Canada Inc. is a pharmaceutical company specializing in research and marketing of therapeutic, corrective and aesthetic solutions for dermatology patients. Our expertise spans a broad spectrum of skin and hair diseases. Our growing portfolio includes treatments for skin conditions such as acne, rosacea, psoriasis, eczema and seborrheic dermatitis.
Galderma Canada Inc. was established in 1989 as an affiliate of Galderma, a global pharmaceutical company. Today, with a staff of 42, half of which is located in Thornhill Ontario, we service approximately 3,000 physicians with a special focus on dermatology.
Galderma Canada at a glance:
- Our growing portfolio includes 8 major brands; Benzac®, Cetaphil®, Capex®, Clobex®, Desocort®, Differin®/ Differin® XPTM, Metro®, Nutraderm®
- Partner in sales and marketing agreements with Elidel® (Novartis®) and Ombrelle® (L’Oreal®)
- Provide 5 M$ for R&D development
- Support the Canadian Dermatology industry with research grants and sponsorships; CDA, CDF, Derm Update, APDA, ADQ, Atlantic Derm
- New Photodynamic Therapy (PDT) business emerges following the 2009 approval of Metvix™ methyl aminolevulinate cream (in combination with specific red light illumination)
Galderma is a global dermatology company. For more information, visit
www.galderma.com
